Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharmacodynamics Study”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT06490939
What this trial is testing

Clinical Trial of Efepoetin Alfa in Healthy Subjects

Who this might be right for
Healthy
Genexine, Inc. 40
Early research (Phase 1)Study completedNCT02812875
What this trial is testing

CA-170 (Oral PD-L1, PD-L2 and VISTA Checkpoint Antagonist) in Patients With Advanced Tumors and Lymphomas

Who this might be right for
Advanced Solid Tumors or Lymphomas
Curis, Inc. 71
Testing effectiveness (Phase 2)Study completedNCT05323812
What this trial is testing

ASURE: Alzheimer Study Using oRal Edaravone

Who this might be right for
Alzheimer Disease
Treeway B.V. 61
Post-approval studies (Phase 4)WithdrawnNCT01116531
What this trial is testing

Efficacy, Safety, Tolerability and Pharmacokinetics of Concomitant Administration of Tramadol With Duloxetine or Pregabalin

Who this might be right for
Diabetic PolyneuropathyPostherpetic Neuralgia
Turku University Hospital
Early research (Phase 1)Study completedNCT00927875
What this trial is testing

BMS-833923 With Carboplatin and Etoposide Followed by BMS-833923 Alone in Subjects With Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Carcinoma
Bristol-Myers Squibb 5
Early research (Phase 1)Study completedNCT07549581
What this trial is testing

SEP-380135 in Adults With Schizophrenia or Major Depressive Episode

Who this might be right for
SchizophreniaMajor Depressive Disorder (MDD)Bipolar Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 43
Testing effectiveness (Phase 2)Study completedNCT04440345
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IBI362 in Overweight or Obesity Subjects

Who this might be right for
Overweight or Obesity
Innovent Biologics (Suzhou) Co. Ltd. 60
Early research (Phase 1)WithdrawnNCT04127695
What this trial is testing

Evaluate the Safety and Tolerability of ABBV-0805 in Patients With Parkinson's Disease

Who this might be right for
Parkinson's Disease
AbbVie
Early research (Phase 1)Study completedNCT03859219
What this trial is testing

Evaluate Safety and Tolerability of Single Ascending Doses of Rozanolixizumab Administered by Subcutaneous Infusion in Healthy Japanese, Chinese and Caucasian Study Participants

Who this might be right for
Healthy-volunteers
UCB Biopharma S.P.R.L. 65
Early research (Phase 1)Study completedNCT01497327
What this trial is testing

Open-Label Hepatic Impairment Study

Who this might be right for
Hepatitis C
Gilead Sciences 24
Early research (Phase 1)Study completedNCT03277573
What this trial is testing

Salsalate in Patients Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Adam Boxer 40
Testing effectiveness (Phase 2)Looking for participantsNCT07536269
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Crinecerfont in Participants With Classic Congenital Adrenal Hyperplasia (CAH) Who Are Less Than 4 Years Old

Who this might be right for
Congenital Adrenal Hyperplasia
Neurocrine Switzerland GmbH 20
Early research (Phase 1)Study completedNCT03939026
What this trial is testing

Safety and Efficacy of ALLO-501 Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell or Follicular Lymphoma

Who this might be right for
Relapsed/Refractory Large B Cell LymphomaRelapsed/Refractory Follicular Lymphoma
Allogene Therapeutics 50
Large-scale testing (Phase 3)Study completedNCT00195208
What this trial is testing

Study Comparing a Pantoprazole Formulation to the Currently Marketed Tablet for GERD and Erosive Esophagitis

Who this might be right for
Gastroesophageal RefluxEsophagitis
Wyeth is now a wholly owned subsidiary of Pfizer 97
Early research (Phase 1)Study completedNCT00841048
What this trial is testing

Phase I Study in Healthy Volunteers to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD4017 After Repeated Ascending Oral Doses

Who this might be right for
Diabetes Mellitus Type 2
AstraZeneca 107
Early research (Phase 1)Study completedNCT01211626
What this trial is testing

Study of ANA773 in Healthy Volunteers and Patients With Hepatitis C Virus (HCV) to Assess Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD)

Who this might be right for
HCV Infection
Hoffmann-La Roche 75
Early research (Phase 1)Study completedNCT00959426
What this trial is testing

A Multiple Dose Study Of PF-04620110 In Overweight And Obese, Otherwise Healthy Volunteers

Who this might be right for
ObesityOverweightHealthy
Pfizer 71
Early research (Phase 1)Enrolling By InvitationNCT07182552
What this trial is testing

Phase I Clinical Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics of NTB003 in Healthy Participants

Who this might be right for
TED
Nanjing Chia-tai Tianqing Pharmaceutical 40
Early research (Phase 1)Study completedNCT02880852
What this trial is testing

Belimumab Phase I Study in Chinese Subjects With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 20
Early research (Phase 1)Not Yet RecruitingNCT07830758
What this trial is testing

Resmetirom in Patients With MASH and HFpEF

Who this might be right for
MASH - Metabolic Dysfunction-Associated SteatohepatitisHeart Failure With Preserved Ejection Fraction (HFPEF)
Madrigal Pharmaceuticals, Inc. 90
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation